Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBK1 | Q9UHD2 | 2/20 | 0.32 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 2/20 | 0.30 |
| ▸ | ACHE | P22303 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12413230 | 0.81 | HPGD (0.39) | CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL12413348 | 0.78 | HPGD (0.37) | CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL12413269 | 0.78 | — | — | |
| SCHEMBL2706167 | 0.70 | BCHE (0.45) | TBK1IKBKEBCHEACHE | |
| SCHEMBL12413405 | 0.69 | HPGD (0.35) | — | |
| SCHEMBL12413225 | 0.69 | HPGD (0.36) | CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL20033064 | 0.68 | LMNA (0.40) | TBK1IKBKEBCHEACHE | |
| SCHEMBL12413241 | 0.68 | HPGD (0.35) | — | |
| SCHEMBL16806112 | 0.67 | BCHE (0.42) | TBK1IKBKEBCHEACHE | |
| SCHEMBL13506889 | 0.64 | TBK1 (0.41) | TBK1IKBKEBCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SCLY, MSRB3, SOD1 | TBK1 2988/4885IKBKE 3726/4885CSNK2A2 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.